1996
DOI: 10.1128/iai.64.12.5000-5007.1996
|View full text |Cite
|
Sign up to set email alerts
|

Candidacidal activity of recombinant human salivary histatin-5 and variants

Abstract: Human salivary histatins possess fungicidal and bactericidal activities. The current investigation evaluates the structure-function relationship of histatins with regard to their candidacidal activity by using recombinant histatin-5 and its variants produced in Escherichia coli. The purified recombinant histatins were examined for their candidacidal activity and secondary structure. The m21 (with Lys-13 replaced by Thr [Lys-133Thr]) and m71 (Lys-133Glu) variants are significantly less effective than recombinan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
41
0

Year Published

1997
1997
2019
2019

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 59 publications
(43 citation statements)
references
References 38 publications
2
41
0
Order By: Relevance
“…A number of histatin variants have been assessed for their antifungal activity. Variant M21 (described earlier) was found to be less potent than histatin 5 (Tsai et al 1996), and dhvar 1 and dhvar 2 (multi-site substitutions in the dh-5 region) displayed lower antifungal activity than histatin 5 (Helmerhorst et al 1997). The variants displayed activity against a number of bacteria but their haemolytic activity rendered them unsuitable for future development.…”
Section: Therapeutic Potential Of Histatinsmentioning
confidence: 92%
See 1 more Smart Citation
“…A number of histatin variants have been assessed for their antifungal activity. Variant M21 (described earlier) was found to be less potent than histatin 5 (Tsai et al 1996), and dhvar 1 and dhvar 2 (multi-site substitutions in the dh-5 region) displayed lower antifungal activity than histatin 5 (Helmerhorst et al 1997). The variants displayed activity against a number of bacteria but their haemolytic activity rendered them unsuitable for future development.…”
Section: Therapeutic Potential Of Histatinsmentioning
confidence: 92%
“…Variant M21 was created by replacing Lys-13 with Thr, while M71 had Lys-13 replaced by Glu. Both variants demonstrated reduced fungicidal activity, indicating that the Lys-13 region was required for antifungal activity (Tsai et al 1996). A similar strategy was adopted in generating variants with multi-site substitutions in the dh-5 region.…”
Section: Structure Of Histatinmentioning
confidence: 99%
“…Construction of the pET-Hsn-5 expression plasmid. For the construction of pET-Hsn-5, Hsn-5 cDNA was recloned from the plasmid pGHsn-5 that we constructed previously (32) into an Escherichia coli pET-30b(ϩ) expression system (18), as follows: the Hsn-5 coding region was PCR amplified from the pGHsn-5 plasmid with primer P1 (5Ј-GCGCCATGGATTCACATGCAAAG AGACATC-3Ј), which annealed to the 5Ј end of the coding region, and primer pGEX#4 (5Ј-TTTCACCGTCATCACCGAAA-3Ј), which annealed to the pGEX-2T sequence about 50 bp downstream of the Hsn-5 stop codon. An NcoI restriction site (CCATGG; underlined in the sequence of primer P1) and a Met codon (ATG; double underlined in the sequence of primer P1) were introduced at the 5Ј end of Hsn-5 for cloning and cyanogen bromide (CNBr) cleavage purposes, respectively.…”
Section: Methodsmentioning
confidence: 99%
“…The samples were then passed through a DE-52 anion exchanger by using 10 mM Tris buffer (pH 8.0) to remove the neutral and acidic peptides generated by CNBr cleavage of the carrier protein. Final purification of Hsn-5 and the two variants was achieved by reversed-phase high-pressure liquid chromatography (RP-HPLC) as described previously (32).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation